BioCryst Pharmaceuticals
BCRX
#4882
Rank
HK$15.51 B
Marketcap
HK$60.30
Share price
0.79%
Change (1 day)
7.70%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): -HK$9.79

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$11.29. In 2022 the company made an earnings per share (EPS) of -HK$10.43 a decrease over its 2021 EPS that were of -HK$8.08.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$9.79-6.14%
2022-HK$10.4329.13%
2021-HK$8.08-4.63%
2020-HK$8.4710.2%
2019-HK$7.680%
2018-HK$7.6825.64%
2017-HK$6.124%
2016-HK$5.8827.12%
2015-HK$4.63-13.24%
2014-HK$5.3323.64%
2013-HK$4.31-30.38%
2012-HK$6.19-37.3%
2011-HK$9.8865.79%
2010-HK$5.96117.14%
2009-HK$2.74-46.15%
2008-HK$5.10-26.97%
2007-HK$6.98-40.67%
2006-HK$11.7648.51%
2005-HK$7.921%
2004-HK$7.8438.89%
2003-HK$5.65-25%
2002-HK$7.53231.03%
2001-HK$2.27-56.72%
2000-HK$5.2591.43%
1999-HK$2.742.94%
1998-HK$2.67-55.84%
1997-HK$6.0411.59%
1996-HK$5.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-HK$24.31 115.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.56-299.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-HK$20.62 82.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-HK$1.57-86.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-HK$11.92 5.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.11 202.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-HK$3.45-69.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$24.94 120.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-HK$26.97 138.89%๐Ÿ‡บ๐Ÿ‡ธ USA